Sarada Preeta Kalainayakan

Statistics

Publications

Citations

393

H-Index

Active since

2014

Affiliations

The University of Texas at Dallas(Current)

The University of Texas Southwestern Medical Center

Sarada Preeta Kalainayakan is an author at The University of Texas at Dallas specializing in oncology, molecular oncology, and oxygen consumption in tumors.

ORCID

Publications per year

2014–2019

Publications

Hypothalamic PGC-1α Protects Against High-Fat Diet Exposure by Regulating ERα

Eugenia Morselli, Esther Fuente-Martín, Brian Finan et al. · Cell Reports · 2014 · 186 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non–Small Cell Lung Cancer Cells

Sagar Sohoni, Poorva Ghosh, Tianyuan Wang et al. · Cancer Research · 2019 · 97 citations

Life Sciences, Biochemistry, Oncology +17

Cyclopamine tartrate, an inhibitor of Hedgehog signaling, strongly interferes with mitochondrial function and suppresses aerobic respiration in lung cancer cells

Md Maksudul Alam, Sagar Sohoni, Sarada Preeta Kalainayakan et al. · BMC Cancer · 2016 · 44 citations · Full text

Medicine, Oncology, Pharmacology +16

The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells

Sanchareeka Dey, Sharda Kumari, Sarada Preeta Kalainayakan et al. · Oncotarget · 2017 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression

Sarada Preeta Kalainayakan, Poorva Ghosh, Sanchareeka Dey et al. · Scientific Reports · 2019 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5